We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Affordable Coagulation Analyzers Provide Broad Testing Range

By LabMedica International staff writers
Posted on 27 Jan 2015
The most common coagulation tests performed include PT, aPTT, and D Dimer. More...
While in some labs there is a need for PT, aPTT, D Dimer, and fibrinogen, others such as (component separation) blood banks routinely perform fibrinogen and Factor VIII. Another customer set, specializing in coagulopathy, tests for certain rare parameters. However, not all available systems are equipped to cater to these requirements. Also in need of immediate attention are: not having small reagent pack sizes for D Dimer and unavailability of timely service in remote areas.

Towards resolution of these critical issues and catering to diverse customer needs, Transasia Bio-Medicals Ltd (Mumbai, India), launched two advanced coagulation analyzers: ERBA ECL 105 – Single Channel and ERBA ECL 412 – Four Channel. Both analyzers use an innovative technology thereby providing highly accurate and precise results at affordable cost.

Both instruments include the following key highlights and features: LCD touchscreen graphical display; built-in incubator for cuvette; facility for reagent incubation through magnetic stirring of reagents (especially beneficial for mixing silica or latex based reagents as they require constant stirring to maintain suspension of particulate matter); inbuilt robust thermal printer; Connectivity through USB ports, ethernet ports, and RFID detection facility; storage of data and coagulation clotting curves is possible on an external drive. The test menu includes comprehensive range of tests from clotting to chromogenic (only onECL 412) and immunologic tests; light scattering principle is used for performing assays - Clotting (640 nm), Chromogenic (405 nm), and D Dimer (800 nm). The software is user-friendly, with minimal, simple logical inputs in programming tests, multi-standard calibration, plotting multilevel quality control (QC) points, and running tests. It also includes proven technology of coagulation curve in percentage light scatter for clot detection.

The ERBA ECL 105/412 performs comprehensive coagulation tests in semiautomated systems. The tests (such as fibrinogen, factors assays, Lupus anticoagulant, AT III (only on ECL 412), Protein C, Protein S, and D Dimer) are programmed and can be performed with minimum effort. The QC plotting has been programmed keeping in mind the accreditation requirement of laboratory. Multilevel QC for each test is possible, a feature still rare in many single- and four-channel analyzers.

Related Links:

Transasia Bio-Medicals



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Gastrointestinal Panel
Xpert® GI Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Image: MPNST is a cancer of the connective tissue surrounding peripheral nerves, with NF1 being a key risk factor (Image Credit: Nephron/Wikimedia Commons (CC BY-SA 3.0)

Liquid Biopsy Shows Promise for Detecting and Monitoring Malignant Nerve Sheath Tumors

Malignant peripheral nerve sheath tumor (MPNST) is one of the most serious cancers affecting people with neurofibromatosis type 1 (NF1), yet timely recognition remains difficult. Clinicians often struggle... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.